ONCOLOGY
Capsules -
| SR NO. | GENERIC NAME | FORMULATION | STRENGTH | |
| 1 | Gefitinib | Capsules | 250mg | send inquiry |
| 2 | Gefitinib | Capsules | 250mg | send inquiry |
| 3 | Hydroxyurea | Capsules | 500 mg | send inquiry |
| 4 | Imatinib mesylate | Capsules | 100 mg | send inquiry |
| 5 | Temozolomide | Capsules | 5mg | send inquiry |
| 6 | Temozolomide | Capsules | 20 mg | send inquiry |
| 7 | Temozolomide | Capsules | 100 mg | send inquiry |
| 8 | Temozolomide | Capsules | 250 mg | send inquiry |
| 9 | Etramustine Phosphate | Capsules | 140 mg | send inquiry |
| 10 | Etoposide | Capsules | 50/ 100 mg | send inquiry |
| 11 | Procarbazine USP | Capsules | 50 mg | send inquiry |
| 12 | Thalidomide USP | Capsules | 50 / 100 mg | send inquiry |
Tablet -
| SR NO. | GENERIC NAME | FORMULATION | STRENGTH | |
| 13 | Anastrozole | Tablet | 1 mg | send inquiry |
| 14 | Bicalutamide | Tablet | 50 / 150 mg | send inquiry |
| 15 | Busulfan | Tablet | 2 mg | send inquiry |
| 16 | Capecitabine | Tablet | 150 mg / 500 mg | send inquiry |
| 17 | Chlorambucil | Tablet | 2 mg | send inquiry |
| 18 | Chlorambucil | Tablet | 5 mg | send inquiry |
| 19 | Cyclophosphamide | Tablet | 50mg | send inquiry |
| 20 | Exemestane | Tablet | 25 mg | send inquiry |
| 21 | Imatinib mesylate | Tablet | 100mg | send inquiry |
| 22 | Imatinib mesylate | Tablet | 400mg | send inquiry |
| 23 | Letrozole | Tablet | 2.5 mg | send inquiry |
| 24 | Melphalan | Tablet | 2 mg | send inquiry |
| 25 | Melphalan | Tablet | 5 mg | send inquiry |
| 26 | Methotrexate | Tablet | 2.5 mg | send inquiry |
| 27 | Methotrexate | Tablet | 5 mg | send inquiry |
| 28 | Tamoxifen Citrate | Tablet | 10 mg | send inquiry |
| 29 | Tamoxifen Citrate | Tablet | 20 mg | send inquiry |
| 30 | Bosutinib | Tablet | 100 / 500 mg | send inquiry |
| 31 | Dasatinib | Tablet | 100 mg | send inquiry |
| 32 | Erlotinib | Tablet | 25 / 100 / 150 mg | send inquiry |
| 33 | Sorafenib | Tablet | 200 mg | send inquiry |
| 34 | Sunitinib | Tablet | 12.5 / 25 / 50 mg | send inquiry |












